Clinical trial
Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in…
NCT00436748 · Amgen, Industry · Terminated
Key facts
| NCT number | NCT00436748 |
|---|---|
| Title | Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease |
| Official title | A Multi-Center, Double-Blind, Randomized Study Evaluating De Novo Weekly and Once Every Two Week Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Subjects With Chronic Kidney Disease Receiving and Not Receiving Dialysis |
| Lead sponsor | Amgen, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia, Chronic Kidney Disease, Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa, Placebo |
| Enrollment | 116 |
| Start date | Sep 16, 2008 |
| Primary completion | Mar 3, 2014 |
| Completion | Mar 3, 2014 |
| First posted | Feb 19, 2007 |
| Last update posted | Nov 29, 2022 |
| Countries | Belgium, Latvia, Lithuania, Mexico, Poland, Puerto Rico, Russia, Slovakia, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: